老年恶性血液病患者的衰弱评估
作者: |
1梁璐,
2薛华
1 河北大学附属医院急诊科,河北 保定 071000 2 河北大学附属医院血液科,河北 保定 071000 |
通讯: |
薛华
Email: xh-xuehua@163.com |
DOI: | 10.3978/j.issn.2095-6959.2022.09.037 |
基金: | 河北省财政厅卫生健康委老年病防治项目(2020)。 |
摘要
Frailty assessment and management for elder adults with hematologic malignancies
CorrespondingAuthor: XUE Hua Email: xh-xuehua@163.com
DOI: 10.3978/j.issn.2095-6959.2022.09.037
Foundation: This work was supported by the Senile Disease Prevention Project of Hebei Provincial Health Commission of Finance Department, China (2020).
Abstract
Hematological malignancies mostly occur in elderly patients, and the combined effects of aging and the mechanisms of hematological malignancies increase the complexity of frailty and treatment. Frailty is associated with poor therapeutic response, increased toxicity, and poor survival in elderly patients with hematological malignancies, making frailty assessment even more important. The frailty assessment of elderly patients with appropriate assessment tools can help determine the tolerance and prognosis of treatment, and can provide individualized treatment for elderly patients with hematological malignancies. Hematological malignancies are heterogeneous and require the development of disease-specific frailty assessment tools based on disease characteristics.